617
Views
7
CrossRef citations to date
0
Altmetric
Endometriosis

Conservative treatment of deep infiltrating endometriosis: review of existing options

ORCID Icon, &
Pages 10-14 | Received 14 Feb 2017, Accepted 16 Sep 2017, Published online: 27 Sep 2017

References

  • Halis G, Mechsner S, Ebert A, et al. The diagnosis and treatment of deep infiltrating endometriosis. Dtsch Arztebl Int 2010;107:446–56.
  • Marana R, Lecca A, Biscione A, et al. [Endometriosis: the gynecologist’s opinion]. Urologia 2012;79:160–6.
  • Cohen J, Ballester M, Selleret L, et al. Finding the balance between surgery and medically-assisted reproduction in women with deep infiltrating endometriosis. Minerva Ginecol 2016;68:642–52.
  • Vercellini P, Frontino G, Pietropaolo G, et al. Deep endometriosis: definition, pathogenesis, and clinical management. J Am Assoc Gynecol Laparosc 2004;11:153–61.
  • Polish Gynecological Society. The position of the experts of polish gynaecological society on the diagnosis and treatment of endometriosis. Polish Gynecol 2012;83:871–6.
  • Puchkova EN, Mershina EA, Sinitsyn VE. Capabilities of magnetic resonance imaging to diagnose infiltrating pelvic endometriosis. Vestn Rentgenol Radiol 2014;3:24–34.
  • Schneider C, Oehmke F, Tinneberg HR, et al. MRI technique for the preoperative evaluation of deep infiltrating endometriosis: current status and protocol recommendation. Clin Radiol 2016;71:179–94.
  • Nisenblat V, Bossuyt PM, Farquhar C, et al. Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016;2:CD009591.
  • Bazot M, Lafont C, Rouzier R, et al. Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis. Fertil Steril 2009;92:1825–33.
  • Goncalves MO, Dias JA Jr, Podgaec S, et al. Transvaginal ultrasound for diagnosis of deeply infiltrating endometriosis. Int J Gynaecol Obstet 2009;104:156–60.
  • Piketty M, Chopin N, Dousset B, et al. Preoperative work-up for patients with deeply infiltrating endometriosis: transvaginal ultrasonography must definitely be the first-line imaging examination. Hum Reprod 2009;24:602–7.
  • Huang XF, Han CN, Lin KQ, et al. Meta-analysis of ultrasonography in diagnosis of deeply infiltrating endometriosis. Zhonghua Fu Chan Ke Za Zhi 2010;45:269–72.
  • Gupta A, Bhatnagar A, Seth BN, et al. Bladder endometriosis mimicking TCC - a case report. J Clin Diagn Res 2016;10:12–13.
  • Noventa M, Saccardi C, Litta P, et al. Ultrasound techniques in the diagnosis of deep pelvic endometriosis: algorithm based on a systematic review and meta-analysis. Fertil Steril 2015;104:366–83.
  • Parazzini F, Viganò P, Candiani M, et al. Diet and endometriosis risk: a literature review. Reprod Biomed Online 2013;26:323–36.
  • Harris HR, Chavarro JE, Malspeis S, et al. Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study. Am J Epidemiol 2013;177:420–30.
  • Ferrero S, Alessandri F, Racca A, et al. Treatment of pain associated with deep endometriosis: alternatives and evidence. Fertil Steril 2015;104:771–92.
  • Api M. Surgery for endometriosis-related pain. Womens Health 2015;11:665–9.
  • De Wilde RL, Alvarez J, Brölmann H, et al. Adhesions and endometriosis: challenges in subfertility management: (An expert opinion of the ANGEL-The ANti-Adhesions in Gynaecology Expert PaneL-group). Arch Gynecol Obstet 2016;294:299–301.
  • De Wilde RL, Bakkum EA, Brölmann H, et al. Consensus recommendations on adhesions (version 2014) for the ESGE Adhesions Research Working Group (European Society for Gynecological Endoscopy): an expert opinion. Arch Gynecol Obstet 2014;290:581–2.
  • Shervin A, Mohazzab A, Aminlou M, et al. Fertility outcome after laparoscopic treatment of advanced endometriosis in two groups of infertile patients with and without ovarian endometrioma. Eur J Obstet Gynecol Reprod Biol 2016;201:46–50.
  • Soriano D, Bouaziz J, Elizur S, et al. Reproductive outcome is favorable after laparoscopic resection of bladder endometriosis. J Minim Invasive Gynecol 2016;23:781–6.
  • Wilczyński M, Wiecka-Płusa M, Antosiak B, et al. Rectovaginal endometriosis: analysis of 160 cases. Ginekol Pol 2015;86:896–901.
  • Araujo SE, Seid VE, Marques RM, et al. Advantages of the robotic approach to deep infiltrating rectal endometriosis: because less is more. J Robot Surg 2016;10:165–9.
  • Meresman GF, Auge L, Barañao RI, et al. Oral contraceptives treatment suppresses proliferation and enhances apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril 2002;77:1141–7.
  • Derouich S, Attia L, Slimani O, et al. [Medical treatment of endometriosis]. Tunis Med 2015;93:407–12.
  • Słopień R, Męczekalski B. Aromatase inhibitors in the treatment of endometriosis. Menopause Review 2016;15:43–7.
  • Tarjanne S, Ng CH, Manconi F, et al. Use of hormonal therapy is associated with reduced nerve fiber density in deep infiltrating, rectovaginal endometriosis. Acta Obstet Gynecol Scand 2015;94:693–700.
  • Chapron C, Souza C, Borghese B, et al. Oral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosis. Hum Reprod 2011;26:2028–35.
  • Bieber EJ, Sanfilippo JS, Horowitz IR. Clinical gynecology. 1st ed. Wroclaw: Elsevier Urban& Partner; 2009:165–185.
  • Leyland N, Casper R, Laberge P, et al. Endometriosis: diagnosis and management. J Obstet Gynaecol Can 2010;32:S1–S32.
  • Angioni S, Pontis A, Dessole M, et al. Pain control and quality of life after laparoscopic en-block resection of deep infiltrating endometriosis (DIE) vs. incomplete surgical treatment with or without GnRHa administration after surgery. Arch Gynecol Obstet 2015;291:363–70.
  • Strowitzki T, Marr J, Gerlinger C, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Human Reprod 2010;25:633–41.
  • Koga K, Takamura M, Fujii T, et al. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil Steril 2015;104:793–801.
  • Agarwal S, Fraser MA, Chen I, et al. Dienogest for the treatment of deep endometriosis: case report and literature review. J Obstet Gynaecol Res 2015;41:309–13.
  • Pontis A, D’Alterio MN, Pirarba S, et al. Adenomyosis: a systematic review of medical treatment. Gynecol Endocrinol 2016;32:1–5.
  • Lan S, Ling L, Jianhong Z, et al. Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis. J Int Med Res 2013;41:548–58.
  • Brown J, Farquhar C. An overview of treatments for endometriosis. JAMA 2015;313:296–7.
  • Fedele L, Bianchi S, Zanconato G, et al. Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001;75:485–8.
  • Efe E, Bakacak M, Serin S, et al. Hormonal treatment for severe hydronephrosis caused by bladder endometriosis. Case Rep Urol 2014;2014:891295.
  • Godin R, Marcoux V. Vaginally administered danazol: an overlooked option in the treatment of rectovaginal endometriosis? J Obstet Gynaecol Can 2015;37:1098–103.
  • Murakami K, Nomura K, Shinohara K, et al. Danazol inhibits aromatase activity of endometriosis-derived stromal cells by a competitive mechanism. Fertil Steril 2006;86:291–7.
  • Ollivierre BA, Cuenca V, Kaufman L. In vitro effect of danazol on endometrioma cells in culture. J Reprod Med 2014;59:13–16.
  • Ferrero S, Tramalloni D, Venturini PL, et al. Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel-releasing intrauterine device. Int J Gynaecol Obstet 2011;113:116–19.
  • Garcia-Velasco JA, Rizk B. Endometriosis current management and future trends. 1st ed. St Louis (MO): Jaypee Medical Publishers; 2010:279–281.
  • Allen C, Hopewell S, Prentice A. Non-steroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev 2005;CD004753.
  • Gibran L, Maranhão RC, Abrão MS, et al. Could statins constitute a novel treatment for endometriosis? Systematic review of the literature. Eur J Obstet Gynecol Reprod Biol 2014;179:153–8.
  • Vitagliano A, Noventa M, Quaranta M, et al. Statins as targeted “magical pills” for the conservative treatment of endometriosis: may potential adverse effects on female fertility represent the “dark side of the same coin”? A systematic review of literature. Reprod Sci 2016;23:415–28.
  • Byrns MC, Penning TM. Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs. Chem Biol Interact 2009;178:221–7.
  • Merviel P, Lourdel E, Sanguin S, et al. Interest of selective progesterone receptor modulators in endometriosis. Gynecol Obstet Fertil 2013; 41:524–8.
  • Ferrero S, Biscaldi E, Luigi Venturini P, et al. Aromatase inhibitors in the treatment of bladder endometriosis. Gynecol Endocrinol 2011;27:337–40.
  • Pontis A, Nappi L, Sorrentino F, et al. Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature. Arch Gynecol Obstet 2017;295:827–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.